Abstract

BackgroundAcetaminophen (AAP) is widely prescribed for treatment of mild pain and fever in western countries. It is generally considered a safe drug and the most frequently reported adverse effect associated with acetaminophen is hepatotoxicity, which generally occurs after acute overdose. During AAP overdose, encephalopathy might develop and contribute to morbidity and mortality. Our hypothesis is that AAP causes direct neuronal toxicity contributing to the general AAP toxicity syndrome.Methodology/Principal FindingsWe report that AAP causes direct toxicity on rat cortical neurons both in vitro and in vivo as measured by LDH release. We have found that AAP causes concentration-dependent neuronal death in vitro at concentrations (1 and 2 mM) that are reached in human plasma during AAP overdose, and that are also reached in the cerebrospinal fluid of rats for 3 hours following i.p injection of AAP doses (250 and 500 mg/Kg) that are below those required to induce acute hepatic failure in rats. AAP also increases both neuronal cytochrome P450 isoform CYP2E1 enzymatic activity and protein levels as determined by Western blot, leading to neuronal death through mitochondrial–mediated mechanisms that involve cytochrome c release and caspase 3 activation. In addition, in vivo experiments show that i.p. AAP (250 and 500 mg/Kg) injection induces neuronal death in the rat cortex as measured by TUNEL, validating the in vitro data.Conclusions/SignificanceThe data presented here establish, for the first time, a direct neurotoxic action by AAP both in vivo and in vitro in rats at doses below those required to produce hepatotoxicity and suggest that this neurotoxicity might be involved in the general toxic syndrome observed during patient APP overdose and, possibly, also when AAP doses in the upper dosing schedule are used, especially if other risk factors (moderate drinking, fasting, nutritional impairment) are present.

Highlights

  • Acetaminophen is considered a nonsteroidal anti-inflammatory (NSAID) drug, even though in clinical practice and in animal models it shows little anti-inflammatory activity [1]

  • Acetaminophen is mainly metabolised in the liver via conjugation with glucuronic acid and sulphate and excreted, but, a small fraction is metabolised by cytochrome P-450 [7,8] forming a chemically reactive metabolite, n-acetyl-pbenzoquinone imine (NAPQI), which reacts with GSH to form a non-toxic conjugate that will be excreted

  • DNA from vehicle, staurosporine- and AAP-treated rat cortical neurons was extracted and samples were subjected to electrophoresis on agarose gel

Read more

Summary

Introduction

Acetaminophen (paracetamol; AAP) is considered a nonsteroidal anti-inflammatory (NSAID) drug, even though in clinical practice and in animal models it shows little anti-inflammatory activity [1]. Like NSAIDs, AAP is used to treat pain and fever and it has become one of the most popular ‘over-the-counter’ non-narcotic analgesic agents. This compound has been taken, at least once, by more than 85% of children under the age of 91 months in the UK [2]. Acetaminophen (AAP) is widely prescribed for treatment of mild pain and fever in western countries It is generally considered a safe drug and the most frequently reported adverse effect associated with acetaminophen is hepatotoxicity, which generally occurs after acute overdose. Our hypothesis is that AAP causes direct neuronal toxicity contributing to the general AAP toxicity syndrome

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call